Initially this study was performed due to the previously known expression of Ly6k in HNSCC, as Ly6k and TEX101 are both part of the same Ly-6/urokinase-type plasminogen activator receptor (LU)-family. Here, BCAM is linked to head and neck squamous cell carcinoma.